6-Acetylaminocaproic acid

HCID 2005

Basic information

CAS
57-08-9
Standard SMILES
CC(=O)NCCCCCC(=O)O
InChIKey
WDSCBUNMANHPFH-UHFFFAOYSA-N
Molecular formula
C8H15NO3
Average molar mass
173.21 g/mol
Monoisotopic mass
173.10519334

Names & identifiers

Preferred name
6-Acetylaminocaproic acid
IUPAC
6-acetamidohexanoic acid
English name
6-Acetamidohexanoic acid
Molecular formula
C8H15NO3
Molecular weight
173.21

Names & synonyms

6-(Acetylamino)hexanoic acid6-Acetylaminocaproic acidepsilon-acetylaminocaproic acidN-acetylamino-6-hexanoic acidRefChem:1092156-Acetamidohexanoic acidacexamic acid57-08-9Hexanoic acid, 6-(acetylamino)-Plastenan6-Acetamidocaproic acidAcide acexamique
Show more names
AACAe-Acetamidocaproic Acid6-acetylaminocaproicacid6-ACETAMINOHEXANOIC ACID
Acetaminocaproic acidCY 153AceminAEAH (base)Acido acexamicoN-Acetyl-6-aminohexanoic acidN-Acetyl-.epsilon.-aminocaproic acid.epsilon.-Acetamidocaproic acid

Database identifiers

CAS
57-08-9
PubChem CID
2005
DTXSID
DTXSID1045879
ChEMBL
CHEMBL2105922
ChEBI
CHEBI:134808
UNII
7IC4BO7D3R
EC Number
200-310-8
Nikkaji
J4.575F

Properties

Computed structural properties

XLogP
0.1
Topological polar surface area
66.4 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
3
Rotatable bonds
6
Heavy atoms
12

Experimental & physicochemical properties

Collision Cross Section141.4 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
102 · 102-104 °C(lit.)
Boiling point
303.86 °C · 303.86°C (rough estimate)
Density
1.1599 · 1.1599 (rough estimate)
refractive index
1.459 · 1.4590 (estimate)
storage temp.
Sealed in dry,Room Temperature
solubility
DMSO (Sparingly), Methanol (Slightly)

Safety & regulation

GHS classification

GHS Classification · 6 items

This chemical does not meet GHS hazard criteria for 50% (2 of 4) of reports.

Danger

H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation];H318 (50%): Causes serious eye damage [Danger Serious eye damage/eye irritation];H335 (50%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 4 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 2 of 4 reports by companies.;There are 2 notifications provided by 2 of 4 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Hazard information

Regulatory Information · 2 items

Chemical: Hexanoic acid, 6-(acetylamino)-

Status: Active Update: 07-02-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/30101

Hazard Classes and CategoriesSkin Irrit. 2 (50%);Eye Dam. 1 (50%);STOT SE 3 (50%)

Regulatory information

Regulatory Information · 2 items

Chemical: Hexanoic acid, 6-(acetylamino)-

Status: Active Update: 07-02-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/30101

Safety data

wgk
3
hs_code
29241900
Signal word
Warning
Symbol(GHS)
GHS07
safety_code
24/25
Hazard statements
H317-H319

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 1 item

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Applications

Useswound healing agent

Uses6-Acetamidohexanoic acid is used after oral administration of an antiulcer agent, zinc acexamate (ZAC) for treatment of gastric ulcer or small bowel inflammation.

Upstream & downstream products

Suppliers90 total

陕西科贝莱药物研发有限公司13119135307 · [email protected]
Hebei Chuanghai Biotechnology Co., Ltd+86-17732866630 · [email protected]
成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
湖北宥澄新材料科技有限公司17764017698 13163370568 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]

Additional notes

DefinitionChEBI: Acexamic acid is a medium-chain fatty acid.

Related reactions

6 records

Compound notes

Loading…